Inventor
RUDOLPH M JONATHAN
US12 patents
⚠️ This page may combine multiple inventors who share the name “RUDOLPH M JONATHAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DIMENSIONAL PHARM INC
6 patentsUS6562840B1May 13, 2003
Heteroaryl amidines, methylamidines and guanidines, and the use thereof as protease inhibitors
DIMENSIONAL PHARM INC16 citations92
US6403633B2Jun 11, 2002
Heteroaryl amidines, methylamidines and guanidines, and use thereof as protease inhibitors
DIMENSIONAL PHARM INC21 citations92
US6291514B1Sep 18, 2001
Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
DIMENSIONAL PHARM INC15 citations92
US7109354B2Sep 19, 2006
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
DIMENSIONAL PHARM INC17 citations91
US6515002B2Feb 4, 2003
Compounds and compositions for treating C1s-mediated diseases and conditions
DIMENSIONAL PHARM INC26 citations90
US6492403B1Dec 10, 2002
Methods of treating C1s-mediated diseases and conditions and compositions thereof
DIMENSIONAL PHARM INC22 citations90
JANSSEN PHARMACEUTICA NV
5 patentsUS7795279B2Sep 14, 2010
Method of inhibiting FLT3 kinase
JANSSEN PHARMACEUTICA NV30 citations92
US7662837B2Feb 16, 2010
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV26 citations91
US7645755B2Jan 12, 2010
Inhibitors of c-fms kinase
JANSSEN PHARMACEUTICA NV45 citations91
US9526731B2Dec 27, 2016
Method of inhibiting C-KIT kinase
JANSSEN PHARMACEUTICA NV0 citations50
US8933091B2Jan 13, 2015
Method of inhibiting C-KIT kinase
JANSSEN PHARMACEUTICA NV0 citations50